John Jaeger

John brings 16 years of Life Sciences Commercial Strategy to Deloitte Consulting, having served most of the world’s largest life sciences clients in the areas of value, access, pricing, commercial and launch strategy. He is focused on bringing solutions to the growing challenge of sustainable pricing, affordability, access, and value capture for within the biopharmaceutical arena – having served >100 unique products from small molecules to cell/gene therapies. 

Prior to joining Deloitte, John led DRG Consulting’s US Pricing and Market Access Practice, which was a commercial strategy consultancy focused on US pricing, reimbursement, and market access. John partners with the life sciences industry to develop innovative solutions focused on optimizing patient access, improving customer engagement, and finding new ways to create and translate value in the market. 

Outside of professional duties, John has presented at multiple leading industry conferences regarding biosimilar commercial strategy and better incorporating value into benefit structures. John has served as an adjunct professor for the University of Sciences MBA program and is a regular guest lecturer for the Rutgers MBA program. In addition,  John currently serves on the National Board of Directors for the Cancer Support Community. In May 2019, John was named the PM360 Elite Mentor Award winner by PM360 Magazine. 

John completed an MPA in Public Health at the University of Delaware and holds a BA in Public Administration from Shippensburg University.